AKRX
- NASDAQ - DRUGS - Drug Manufacturers - Other
Akorn Inc
|
$27.65 |
-0.16 -0.58%
|
$28.00
|
$27.99
|
-1.21% |
606,149 76.63%
|
791,000
|
Most Recent Note for AKRX - 2/25/2014 12:05:59 PM
Hit a new 52-week high with a gap up on the prior session adding to a recent spurt of volume-driven gains. The 2/24/14 mid-day report cautioned members - "Undercut its 50 DMA line during its consolidation then rebounded since noted with caution in the 12/24/13 mid-day report - 'Reported earnings +7% on +18% sales revenues for the quarter ended September 30, 2013 versus the year ago period. Prior quarterly comparisons showed stronger sales revenues and earnings increases which were waning. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ALSN
- NYSE - Auto/Truck-Original Eqp
Allison Transmission Hld
|
$29.50 |
-1.00 -3.28%
|
$29.58
|
$31.27
|
-5.66% |
6,292,076 804.61%
|
782,000
|
Most Recent Note for ALSN - 2/25/2014 12:07:06 PM
Gapped down today. Fundamentals are not a match with the fact-based investment system's guidelines (C and A criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ATMI
- NASDAQ - ELECTRONICS - Semiconductor Equipment & Mate
A T M I Inc
|
$34.30 |
+0.39
1.15%
|
$34.33
|
$34.18
|
0.35% |
763,063 98.46%
|
775,000
|
Most Recent Note for ATMI - 2/25/2014 12:08:04 PM
Still hovering at its 52-week high, holding its ground stubbornly after a considerable gap up on 2/04/14 news it will be acquired by Entegris Inc for about $1.15 billion. Reported earnings +52% on +6% sales revenues for the Dec '13 quarter but fundamental concerns remain. The 7/24/13 mid-day report cautioned members - "Quarterly and annual earnings (C and A criteria) history are not a good match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DPZ
- NYSE - Retail-Restaurants
Dominos Pizza Inc
|
$74.88 |
+0.19
0.25%
|
$77.74
|
$74.84
|
0.05% |
671,704 122.80%
|
547,000
|
Most Recent Note for DPZ - 2/25/2014 12:09:37 PM
Hitting a new 52-week high today with its 4th consecutive gain on ever-increasing volume. Rebounded from below its 50 DMA line since last noted in the 2/05/14 mid-day report with caution. Reported earnings +22% on +5% sales revenues for the Dec '13 quarter. Prior mid-day reports repeatedly cautioned - "Fails to meet the fundamental guidelines of the fact-based system. "
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ESTE
- AMEX - Oil&Gas-U S Expl&Prod
Earthstone Energy Inc
|
$22.13 |
+0.94
4.42%
|
$22.45
|
$21.57
|
2.58% |
31,477 1,049.23%
|
3,000
|
Most Recent Note for ESTE - 2/25/2014 12:14:38 PM
Reported strong sales revenues and earnings increases in the 3 latest quarterly comparisons through Dec '13 satisfying the C criteria. Technically, it broke out with a gap up and volume-driven gain on 2/14/14 and followed through with additional confirming gains for new 52-week highs. Faces some resistance at multi-year highs in the $25-26 area. There is a very small supply of only 1.25 million shares (S criteria) in the float and only 3 top-rated funds (I criteria) own its shares.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LOAN
- NASDAQ - Finance-Commercial Loans
Manhattan Bridge Capital
|
$2.10 |
+0.06
2.94%
|
$2.10
|
$2.30
|
-8.70% |
7,629 84.77%
|
9,000
|
Most Recent Note for LOAN - 2/25/2014 12:16:53 PM
Quarterly earnings increases have been at or above the +25% minimum guideline (C criteria) but its annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MGIC
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Application Software
Magic Software Enter Ltd
|
$9.05 |
-0.09 -0.98%
|
$9.05
|
$9.27
|
-2.37% |
133,273 99.46%
|
134,000
|
Most Recent Note for MGIC - 2/25/2014 12:17:54 PM
Pulling back today after hitting another new 52-week high with a volume-driven gain on the prior session. No resistance remains due to overhead supply. Reported earnings +14% on +13% sales revenues for the Dec '13 quarter. Prior mid-day reports repeatedly cautioned members - "This Israel-based Computer - Tech Services firm's quarterly earnings history has been below the +25% minimum guideline (C criteria) but improved in the Sep '13 quarter. It has a strong annual earnings (A criteria) history. Low priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MNST
- NASDAQ - MEDIA - Advertising Agencies
Monster Beverage Corp
|
$72.07 |
-2.45 -3.29%
|
$73.75
|
$75.63
|
-4.71% |
1,165,937 80.19%
|
1,454,000
|
Most Recent Note for MNST - 2/25/2014 12:19:55 PM
Gapped down today, retreating from its 52-week high. A 2:1 split impacted its share prices as of 2/16/12. Strong annual earnings (A criteria) history. Recent quarterly comparisons through Sep '13 showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$48.08 |
+2.26
4.93%
|
$48.25
|
$46.25
|
3.96% |
1,595,469 94.29%
|
1,692,000
|
Most Recent Note for NVO - 2/25/2014 12:20:54 PM
Powering to another new all-time high with a gap up gain today, on track for its 6th consecutive weekly gain. Reported earnings +14% on +8% sales revenues for the Dec '13 quarter, a 2nd consecutive quarterly comparison with earnings below the +25% guideline (C criteria). It has earned high ranks after demonstrating strong steady annual earnings (A criteria) growth. This Denmark-based Medical - Ethical Drug firm has seen the number of top-rated funds owning its shares fall from 232 in Mar '13 to 200 in Dec '13, not a good sign concerning the I criteria.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PACR
- NASDAQ - TRANSPORTATION - Air Delivery & Freight Service
Pacer International Inc
|
$8.95 |
+0.03
0.34%
|
$8.96
|
$9.23
|
-3.03% |
1,038,465 200.09%
|
519,000
|
Most Recent Note for PACR - 2/25/2014 12:21:57 PM
Still holding its ground in a tight range since gapping up on 1/06/14 news XPO Logistics (XPO), a transportation services specialist, will acquire Pacer International for $335 million, a deal that would make it the third largest intermodal services providers in North America. Fundamental concerns remain. Prior mid-day reports cautioned members - "Sales and earnings history below guidelines. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SGY
- NYSE - ENERGY - Independent Oil & Gas
Stone Energy Corp
|
$34.21 |
-2.42 -6.61%
|
$35.43
|
$37.96
|
-9.88% |
883,396 126.02%
|
701,000
|
Most Recent Note for SGY - 2/25/2014 12:24:04 PM
Gapped down today after challenging prior highs in the $35-38 area with recent volume-driven gains. The 2/14/14 mid-day report cautioned members - "Prior quarters and its annual earnings (A criteria) history has been up and down and rather erratic."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
STRT
- NASDAQ - AUTOMOTIVE - Auto Parts
Strattec Security Corp
|
$61.90 |
-0.50 -0.80%
|
$62.92
|
$66.28
|
-6.61% |
16,034 106.89%
|
15,000
|
Most Recent Note for STRT - 2/25/2014 12:25:07 PM
Hovering at its 52-week high following a spurt of volume-driven gains. Prior mid-day reports cautioned members - "Reported earnings +56% on +13% sales revenues for the Dec '13 quarter, above the +25% minimum earnings guideline (C criteria) but prior quarterly comparisons were sub par and fundamental concerns remain."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
UEIC
- NASDAQ - CONSUMER DURABLES - Electronic Equipment
Universal Electronics
|
$41.20 |
-1.58 -3.69%
|
$42.50
|
$43.25
|
-4.74% |
74,408 89.65%
|
83,000
|
Most Recent Note for UEIC - 2/25/2014 12:25:58 PM
Pulling back today from a new 52-week high hit on the prior session with above average volume behind its 3rd consecutive big gain. Reported earnings +17% on +16% sales revenues for the Dec '13 quarter versus the year ago period. Prior mid-day reports cautioned members - "Prior quarterly comparisons were sub par, not a match with the fact-based investment system's guidelines (C criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VASC
- NASDAQ - HEALTH SERVICES - Medical Instruments & Supplies
Vascular Solutions
|
$25.27 |
+0.19
0.76%
|
$25.27
|
$25.93
|
-2.55% |
59,646 97.78%
|
61,000
|
Most Recent Note for VASC - 2/25/2014 12:27:11 PM
Reported earnings +22% on +15% sales revenues for the Dec '13 quarter, its 3rd consecutive quarter below the +25% minimum guideline (C criteria). Hovering near its 52-week high. Noted repeatedly in prior mid-day reports - "Fundamentals are still not a match with the fact-based investment system's guidelines".
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VC
- NYSE - AUTOMOTIVE - Auto Parts
Visteon Corporation
|
$86.19 |
+0.58
0.68%
|
$88.00
|
$88.74
|
-2.87% |
515,755 83.05%
|
621,000
|
Most Recent Note for VC - 2/25/2014 12:29:33 PM
Approaching its 52-week high with today's 3rd consecutive volume-driven gain. Found prompt support near its 50 DMA line during its consolidation since last noted with caution in the 1/15/14 mid-day report. Reported earnings -4% on +7% sales revenues for the Dec '13 quarter, and fundamental concerns remain. Quarterly and annual earnings history (C and A criteria) are not a match with the fact-based investment system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WX
- NYSE - DRUGS - Drug Manufacturers - Other
Wuxi Pharmatech Inc Ads
|
$39.64 |
-0.22 -0.55%
|
$40.72
|
$40.61
|
-2.39% |
665,582 90.19%
|
738,000
|
Most Recent Note for WX - 2/25/2014 12:32:16 PM
Perched at its 52-week high after clearing the previously noted sound base pattern with its 5th consecutive gain marked by increasing volume. The 2/24/14 mid-day report cautioned members - "No resistance remains due to overhead supply. Reported earnings +31% on +17% sales revenues for the Sep '13 quarter, a 2nd comparison above the +25% minimum guideline, but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|